Dr. Anil Arjundas Kukreja is a distinguished medical affairs leader in the Indian pharmaceutical industry, serving as Vice President – Medical Affairs & Regulatory at AstraZeneca India, where he steers scientific strategy, clinical engagement, and regulatory partnerships to advance patient-centric healthcare solutions across major non-communicable disease (NCD) areas. In this role, he integrates rigorous medical science with strategic outreach to clinicians, policymakers, and healthcare ecosystems—championing education, evidence-based clinical practice, and holistic disease management in areas such as respiratory health, oncology, kidney disease, and cardiometabolic care.

Throughout his tenure at AstraZeneca India, Dr. Kukreja has been a key voice in shaping ‘beyond-the-pill’ initiatives that extend the impact of innovative therapies into real-world care models. He has led efforts to launch and scale Centers of Excellence for severe asthma, partnering with healthcare institutions to establish systematic, multidisciplinary approaches for diagnosis, patient counselling, and biologic therapy initiation—aiming to improve outcomes and standardize respiratory care nationwide.

His leadership extends into collaborative programs that address broader disease burden and awareness. Dr. Kukreja has driven partnerships with professional societies such as the Indian Society of Nephrology to launch educational platforms like the Chronic Kidney Disease (CKD) Academy, designed to equip primary care physicians with critical knowledge for early detection and management of CKD—underscoring his commitment to clinician education as a cornerstone of improved patient outcomes.

Under his guidance, AstraZeneca has also entered strategic collaborations to strengthen diagnostic and therapeutic ecosystems, including alliances with diagnostic partners to enhance breast cancer testing and efforts to integrate precision diagnostics into clinical practice. His focus on addressing the continuum of care—from screening and diagnosis to treatment optimization—reflects an integrated vision for medical affairs in India’s evolving healthcare landscape.

Known for championing evidence-driven engagement with healthcare professionals, Dr. Kukreja advances AstraZeneca’s mission to reduce disease burden through a combination of innovative science, education, and multi-stakeholder collaboration. His work exemplifies how medical affairs leadership can transform scientific insight into meaningful improvements in clinical practice and patient care.